Unilever recalled several dry shampoos because they may contain “elevated levels” of the chemical, which can be a carcinogen at high levels of prolonged exposure.
Health
Health and lifestyle stories from the Portland Press Herald.
UNE team gets $6.6 million grant to explore eye pain, potential treatments
With the National Eye Institute award, a University of New England scientist will look at how eye damage takes its physical and emotional toll.
Abortion ruling means more births, more infant deaths in Mississippi
Mississippi has the nation’s highest fetal mortality rate, highest infant mortality rate, highest pre-term birth rate and is among the worst states for maternal mortality.
Mills, LePage clash on health care policies
The gubernatorial candidates have diverging views and records on how to handle opioids, the pandemic and other issues.
Stress eating? How to train your brain to crave healthy foods
Stress and anxiety can promote belly fat and cravings, making you eat more. But you can train your brain to crave healthier foods during stressful times.
Maine hospitals seeing spike in children’s respiratory virus
Respiratory syncytial virus is a common virus that usually causes cold-like symptoms. One to two out of every 100 children younger than 6 months with an RSV infection are hospitalized.
Wastewater surveillance remains a novel, yet important, tool for tracking the pandemic
‘One piece of the puzzle’: Ten months since Maine launched its wastewater surveillance program, experts are still figuring out the best way to use the data.
Maine hospitals receive $25 million in pandemic recovery funds as patient counts rise again
The $25 million is the latest in a series of payouts included in the state’s supplemental budget approved in April.
Whites are now more likely to die from covid than Blacks. Here’s why the pandemic shifted.
As the pandemic progressed, the damage done by the coronavirus broadened, and the toxicity of modern-day politics came to the fore.
FDA panel backs removal of unproven pregnancy drug
Some panelists encourage drug company Covis to continue studying the drug to determine if a subgroup of women could benefit.